42 research outputs found
Atividade alelopática de folhas e pseudofrutos de Hovenia dulcis Thunb. (Rhamnaceae) sobre a germinação de Lactuca sativa L. (Asteraceae)
Efeito alelopático de frutos de umbu (Phytolacca dioica L.) sobre a germinação e crescimento inicial de alface e picão-preto
Phytotoxic activity of crude aqueous extracts and fractions of young leaves of Sapindus saponaria L. (Sapindaceae)
Phytotoxic potential of young leaves from Blepharocalyx salicifolius (Kunth) O. Berg (Myrtaceae)
Evolution of the use of corticosteroids for the treatment of hospitalised COVID-19 patients in Spain between March and November 2020: SEMI-COVID national registry
Objectives: Since the results of the RECOVERY trial, WHO recommendations about the use of corticosteroids (CTs) in COVID-19 have changed. The aim of the study is to analyse the evolutive use of CTs in Spain during the pandemic to assess the potential influence of new recommendations. Material and methods: A retrospective, descriptive, and observational study was conducted on adults hospitalised due to COVID-19 in Spain who were included in the SEMI-COVID- 19 Registry from March to November 2020. Results: CTs were used in 6053 (36.21%) of the included patients. The patients were older (mean (SD)) (69.6 (14.6) vs. 66.0 (16.8) years; p < 0.001), with hypertension (57.0% vs. 47.7%; p < 0.001), obesity (26.4% vs. 19.3%; p < 0.0001), and multimorbidity prevalence (20.6% vs. 16.1%; p < 0.001). These patients had higher values (mean (95% CI)) of C-reactive protein (CRP) (86 (32.7-160) vs. 49.3 (16-109) mg/dL; p < 0.001), ferritin (791 (393-1534) vs. 470 (236- 996) µg/dL; p < 0.001), D dimer (750 (430-1400) vs. 617 (345-1180) µg/dL; p < 0.001), and lower Sp02/Fi02 (266 (91.1) vs. 301 (101); p < 0.001). Since June 2020, there was an increment in the use of CTs (March vs. September; p < 0.001). Overall, 20% did not receive steroids, and 40% received less than 200 mg accumulated prednisone equivalent dose (APED). Severe patients are treated with higher doses. The mortality benefit was observed in patients with oxygen saturation </=90%. Conclusions: Patients with greater comorbidity, severity, and inflammatory markers were those treated with CTs. In severe patients, there is a trend towards the use of higher doses. The mortality benefit was observed in patients with oxygen saturation </=90%
Genetic Sharing with Cardiovascular Disease Risk Factors and Diabetes Reveals Novel Bone Mineral Density Loci.
Bone Mineral Density (BMD) is a highly heritable trait, but genome-wide association studies have identified few genetic risk factors. Epidemiological studies suggest associations between BMD and several traits and diseases, but the nature of the suggestive comorbidity is still unknown. We used a novel genetic pleiotropy-informed conditional False Discovery Rate (FDR) method to identify single nucleotide polymorphisms (SNPs) associated with BMD by leveraging cardiovascular disease (CVD) associated disorders and metabolic traits. By conditioning on SNPs associated with the CVD-related phenotypes, type 1 diabetes, type 2 diabetes, systolic blood pressure, diastolic blood pressure, high density lipoprotein, low density lipoprotein, triglycerides and waist hip ratio, we identified 65 novel independent BMD loci (26 with femoral neck BMD and 47 with lumbar spine BMD) at conditional FDR < 0.01. Many of the loci were confirmed in genetic expression studies. Genes validated at the mRNA levels were characteristic for the osteoblast/osteocyte lineage, Wnt signaling pathway and bone metabolism. The results provide new insight into genetic mechanisms of variability in BMD, and a better understanding of the genetic underpinnings of clinical comorbidity
Estudo fitoquímico de folhas de Solanum lycocarpum A. St.-Hil (Solanaceae) e sua aplicação na alelopatia
(Phytochemistry of Solanum lycocarpum A.St.–Hil (Solanaceae) leaves and their application in allelopathy). Solanum
lycocarpum A.St.-Hil (Solanaceae) is a typical shrub in the Cerrado of central Brazil. The allelopathic activity of aqueous extracts of the leaves and fruits of this species has already been proven in previous studies. The goal of this work was to verify the allelopathic activity of different leaf extracts of S. lycocarpum on the germination and growth of four target species. The leaves were collected, dried, triturated and submitted to two distinct methods of extraction: 1- liquid--liquid (ethyl acetate and dichloromethane) from the aqueous extract and 2- with solvents of increasing polarities (hexane, dichloromethane, ethyl acetate, acetone, methanol and water) directly from the leaves. Each extraction was made with ultrasound equipment for one hour, filtered and evaporated. From these extracts, solutions of 800, 400 and 200 ppm were prepared, and water and Logran® were used as positive and negative controls, respectively. Each solution, as well as the controls, was dissolved in DMSO for the bioassays. The target species used were lettuce, watercress, tomato and onion. To each plate, 20 seeds were added and 1 mL of the tested solutions (with 4 repetitions). The plates were incubated at 25 oC without light, and the shoots and roots of the seedlings were then measured and the percentage of germination and the inhibition of each extract were calculated. Tomato was the most sensitive to the extracts, followed by watercress, onion and lettuce. The extracts with stronger activity were AcOEt, acetone and the liquid-liquid extraction, indicating the fractions that may contain the active principles of the leaves in this species
New insights into the genetic etiology of Alzheimer's disease and related dementias
Characterization of the genetic landscape of Alzheimer's disease (AD) and related dementias (ADD) provides a unique opportunity for a better understanding of the associated pathophysiological processes. We performed a two-stage genome-wide association study totaling 111,326 clinically diagnosed/'proxy' AD cases and 677,663 controls. We found 75 risk loci, of which 42 were new at the time of analysis. Pathway enrichment analyses confirmed the involvement of amyloid/tau pathways and highlighted microglia implication. Gene prioritization in the new loci identified 31 genes that were suggestive of new genetically associated processes, including the tumor necrosis factor alpha pathway through the linear ubiquitin chain assembly complex. We also built a new genetic risk score associated with the risk of future AD/dementia or progression from mild cognitive impairment to AD/dementia. The improvement in prediction led to a 1.6- to 1.9-fold increase in AD risk from the lowest to the highest decile, in addition to effects of age and the APOE ε4 allele